Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,593 High Cholesterol
clinical trials

Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Morristown, NJ
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Portland, OR
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Spokane, WA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
St Louis, MO
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
A Thorough Corrected QT Interval Trial
Status: Enrolling, Phase I
Updated: 2/25/2014
mi
from
Austin, TX
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Camp Hill, PA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Canton, OH
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Great Falls, MT
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Hollywood, FL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Metairie, LA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Monroe, LA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Munster, IN
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
New Windsor, NY
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Plano, TX
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
St. Louis, MO
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Toledo, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Evansville, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Greensboro, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Jackson, MS
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Jupiter, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Kingsport, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Marion, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Newton, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Willoughby Hills, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Crestview, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Kingwood, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Minden, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Monroe, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Willoughby, OH
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Ogden, UT
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Rockville, MD
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Springfield, IL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
Status: Enrolling, Phase IV
Updated: 3/16/2016
mi
from
Bend, OR
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
Status: Enrolling, Phase IV
Updated: 3/16/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Boise, ID
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Clearwater, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Rapid City, SD
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Richmond, VA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Winter Haven, FL
Click here to add this to my saved trials
Severe Familial Hypercholesterolemia Clinical Trial
Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders
Status: Enrolling, Phase II, III
Updated: 3/11/2015
mi
from
Nashville, TN
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial
Status: Enrolling
Updated: 6/26/2013
mi
from
Detroit, MI
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial
Status: Enrolling
Updated: 6/26/2013
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial
Status: Enrolling
Updated: 6/26/2013
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial
Status: Enrolling
Updated: 6/26/2013
mi
from
South Portland, ME
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Study to Assess the Safety and Tolerability of Single Doses of REGN1500
Status: Enrolling, Phase I
Updated: 11/9/2015
mi
from
Miramar, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling, Phase III
Updated: 2/24/2014
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling, Phase III
Updated: 2/24/2014
mi
from
Lancaster, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling, Phase III
Updated: 2/24/2014
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling, Phase III
Updated: 2/24/2014
mi
from
Omaha, NE
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Status: Enrolling, Phase III
Updated: 4/29/2015
mi
from
St. Louis, MO
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Fargo, ND
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Little Rock, AR
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Melbourne, FL
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Oak Ridge, TN
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Orange, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Endwell, NY
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Miami, FL
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Olive Branch, MS
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Spring Valley, CA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
St Louis, MO
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Towson, MD
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Ventura, CA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Williamsville, NY
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
York, PA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)
Status: Enrolling, Phase III
Updated: 4/16/2014
mi
from
Fall River, MA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Beaver, PA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Boston, MA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Bountiful, UT
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Clearwater, FL
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Dallas, TX
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Golden, CO
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Alhambra, CA
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16